CTRI/2021/08/036033已完成未知
Plasma L-Asparginase Activity Assay (AAA) in children with Acute Lymphoblastic Leukemia/Lymphoma (ALL) after administration of Pegylated L-Asparginase: A prospective pilot Study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All children less than 18 years with Acute Lymphoblastic Leukemia/Lymphoblastic Leukemia on
- •curative intent and receiving Pegylated L Asparginase
排除标准
- •Any child with Acute Lymphoblastic Leukemia and Downs Syndrome
研究者
相似试验
进行中（未招募）
1 期
The aim of the study is to monitor the activity of Asparaginase, an enzyme that acts by degrading asparagine, an important component of proteins without which cells can not survive.Normal cells can produce asparagine independently, while some cancer cells are unable to do so. Asparaginase reduces the level of asparagine in the blood cells and stops the growth of cancer cells.Adult patients, aged between 18 and 65, diagnosed with Acute Ph Lymphoblastic Leukemia negative (LAL Ph-) untreated, with a favorable impact on the prognosis.MedDRA version: 21.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2018-003517-17-ITFONDAZIONE GIMEMA (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) FRANCO MANDELLI ONLUS52
终止
1 期
L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBLLymphoblastic LymphomaAcute Lymphoblastic LeukemiaNCT01910428ERYtech Pharma14
已完成
3 期
05-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenDrug/Agent Toxicity by Tissue/OrganLeukemiaNCT00400946Dana-Farber Cancer Institute800
Unknown
不适用
A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic LeukaemiaAcute Lymphoblastic LeukaemiaNCT01272440Aarhus University Hospital200
撤回
2 期
An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)NCT02150928Jazz Pharmaceuticals